Cough

·MeSH: Chronic Cough

15 drugs in development·9 companies·5 clinical trials

Drug Pipeline by Phase

Approved(8)

Drug	Company
dextromethorphan polistirex	Amneal Pharmaceuticals, Inc. (AMRX)
Double - Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
Double-Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
guaifenesin	PERRIGO Co plc (PRGO)
guaifenesin	DR REDDYS LABORATORIES LTD (RDY)
guaifenesin	SUNSET ISLAND GROUP (SUN)
guaifenesin	Amneal Pharmaceuticals, Inc. (AMRX)
guaifenesin	BRIGHT MINDS BIOSCIENCES INC. (DRUG)

Phase 3(4)

Drug	Company
blu-5937	GSK plc (GLAXF)
blu-5937	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
blu-5937 er	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
blu-5937 ir	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)

Phase 1(3)

Drug	Company
camlipixant	GSK plc (GLAXF)
camlipixant	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
nal er	Trevi Therapeutics, Inc. (TRVI)

BioSniper tracks 15 drugs in development for Cough across 9 companies.

There are 5 clinical trials targeting Cough tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.